Prot#D1690C00078: A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Trial to Evaluate the Effect of In-Hospital Initiation of Dapagliflozin on Clinical Outcomes in Patients with Heart Failure with Reduced Ejection Fraction Who Ha

Project: Research project

Project Details

StatusActive
Effective start/end date2/18/212/18/27

Funding

  • TIMI Study Group (Prot#D1690C00078 // Prot#D1690C00078)
  • AstraZeneca Pharmaceuticals LP (Prot#D1690C00078 // Prot#D1690C00078)